OC
SGYP

Oppenheimer & Co’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Oppenheimer & Co’s Portfolio SGYP Stock Details SGYP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-90,613
Closed -$262K – 1387
2017
Q3 		$262K Sell
90,613
-4,677
-5% -$16K 0.01% 1087
2017
Q2 		$424K Buy
95,290
+12,003
+14% +$49.5K 0.01% 890
2017
Q1 		$388K Buy
+83,287
New +$483K 0.01% 899
2013
Q4 		– Sell
-75,036
Closed -$338K – 1475
2013
Q3 		$338K Buy
75,036
+5,070
+7% +$22.7K 0.01% 920
2013
Q2 		$298K Buy
+69,966
New +$352K 0.01% 933

Other funds holding SGYP

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $77.3B AUM 36.07% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $1.6B AUM 121.58% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.6B AUM 47.77% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return